We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$459B
AUM Growth
+$54.2B
Cap. Flow
+$30.4B
Cap. Flow %
6.63%
Top 10 Hldgs %
17.11%
Holding
10,551
New
1,098
Increased
4,837
Reduced
3,046
Closed
1,108

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.07B
2
TSLA icon
Tesla
TSLA
+$467M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$262M
4
MTCH icon
Match Group
MTCH
+$241M
5
VLO icon
Valero Energy
VLO
+$212M

Sector Composition

Rank Sector Weight
1 Technology 16.89%
2 Financials 8.35%
3 Healthcare 6.45%
4 Consumer Discretionary 5.39%
5 Communication Services 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITS
7001
Lite Strategy Inc
LITS
$29.6M
$36.7K ﹤0.01%
12,878
+4,778
+59% +$14.9K
NOTE
7002
DELISTED
FiscalNote
NOTE
$36.7K ﹤0.01%
2,386
+837
+54% +$14.6K
ACRS icon
7003
Aclaris Therapeutics
ACRS
$868M
$36.6K ﹤0.01%
31,852
-1,939
-6% -$2.38K
XRLX icon
7004
FundX Conservative ETF
XRLX
$49.1M
$36.6K ﹤0.01%
+841
New +$35.6K
AWX icon
7005
Avalon Holdings
AWX
$10.9M
$36.6K ﹤0.01%
+14,349
New +$34.4K
OSS icon
7006
One Stop Systems
OSS
$315M
$36.6K ﹤0.01%
15,301
-10,781
-41% -$23.9K
ICCM icon
7007
IceCure Medical
ICCM
$11.2M
$36.5K ﹤0.01%
+1,996
New +$40.5K
TGS icon
7008
Transportadora de Gas del Sur
TGS
$4.41B
$36.5K ﹤0.01%
1,988
-1,419
-42% -$26.7K
VHC icon
7009
VirnetX Holding Corp
VHC
$60M
$36.5K ﹤0.01%
5,171
+4,239
+455% +$28.1K
RDNW
7010
RideNow Group
RDNW
$248M
$36.3K ﹤0.01%
7,584
+2,619
+53% +$10.8K
SUSL icon
7011
iShares ESG MSCI USA Leaders ETF
SUSL
$1.21B
$36.2K ﹤0.01%
+357
New +$35K
WBIY icon
7012
WBI Power Factor High Dividend ETF
WBIY
$62.2M
$36.2K ﹤0.01%
1,154
+368
+47% +$11.1K
GLMD icon
7013
Galmed Pharmaceuticals
GLMD
$4.9M
$36.1K ﹤0.01%
5,267
+5,244
+22,800% +$22.9K
OVID icon
7014
Ovid Therapeutics
OVID
$489M
$36.1K ﹤0.01%
30,612
+9,420
+44% +$9.84K
UBOT icon
7015
Direxion Daily Robotics Artificial Intelligence & Automation Index Bull 2X ETF
UBOT
$26.6M
$36.1K ﹤0.01%
1,525
SYRS
7016
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$36K ﹤0.01%
16,728
-4,825
-22% -$17.3K
BLCN
7017
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$35.8K ﹤0.01%
1,431
+897
+168% +$22.9K
BDCZ icon
7018
ETRACS MarketVector Business Development Companies Liquid Index ETN due Apr 26 2041
BDCZ
$16.4M
$35.8K ﹤0.01%
1,879
+1,426
+315% +$27.1K
AXIA.PR
7019
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$35.8K ﹤0.01%
+5,714
New +$35.6K
NE.WS icon
7020
Noble Corporation PLC Tranche 1 Warrants
NE.WS
$35.7K ﹤0.01%
1,983
-208
-9% -$4.65K
KTTA icon
7021
Pasithea Therapeutics
KTTA
$15.8M
$35.6K ﹤0.01%
6,567
+6,529
+17,182% +$32.2K
TNXP icon
7022
Tonix Pharmaceuticals
TNXP
$201M
$35.6K ﹤0.01%
2,403
+2,402
+240,200% +$96.7K
NE.WS.A icon
7023
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
$35.4K ﹤0.01%
2,512
+1,371
+120% +$24.9K
KOPN icon
7024
Kopin
KOPN
$780M
$35.4K ﹤0.01%
48,427
+48,294
+36,311% +$44.3K
MXF
7025
Mexico Fund
MXF
$315M
$35.3K ﹤0.01%
2,342
-1,896
-45% -$29.5K

Similar funds

UBS Group's Q3 2024 Portfolio in Review

As of Q3 2024, UBS Group held 10,551 positions worth $459B, up 13% from $405B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $30.4B of net new capital in Q3 2024, opening 1,098 new positions and adding to 4,837 existing holdings. Its largest new stake was Smurfit Westrock: 973,061 shares worth $48.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Nike, an estimated $1.07B trimmed.

  • UBS Group's largest Q3 2024 buy was Smurfit Westrock: 973,061 shares worth $48.1M.
  • UBS Group added most to Meta Platforms (Facebook) in Q3 2024, an estimated $694M increase.
  • UBS Group's biggest Q3 2024 reduction was Nike, cutting an estimated $1.07B.
  • UBS Group fully exited WestRock Company in Q3 2024, selling an estimated $161M.
  • UBS Group's ten largest holdings make up 17% of its $459B portfolio in Q3 2024.
  • UBS Group opened 1,098 new positions and closed 1,108 in Q3 2024.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $459B.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.